SCHEMBL8998965

SCHEMBL8998965

Cn1c(Br)c(C(=O)O)c2ccccc21

nearest known ligand 0.63

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
EGFR P00533 8/20 0.63
SRC P12931 8/20 0.51
KDM4E B2RXH2 2/20 0.50
ALDH1A1 P00352 3/20 0.48
NPC1 O15118 2/20 0.48
MAPT P10636 1/20 0.48
HTT P42858 1/20 0.48
RAB9A P51151 1/20 0.48
ATM Q13315 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
NPSR1 Q6W5P4 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
GPR3 P46089 1/20 0.47
FGFR1 P11362 1/20 0.47
POLB P06746 1/20 0.46
HPGD P15428 1/20 0.46
AGTR1 P30556 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20598597 0.81 SRC (0.55) EGFRSRCKDM4EALDH1A1NPC1
SCHEMBL30443220 0.80 EGFR (0.65) EGFRSRCKDM4EALDH1A1NPC1
SCHEMBL984736 0.80 EGFR (0.65) EGFRSRCKDM4EALDH1A1NPC1
SCHEMBL11811603 0.80 EGFR (0.65) EGFRSRCKDM4EALDH1A1NPC1
SCHEMBL9690808 0.79 EGFR (0.68) EGFRSRCKDM4EALDH1A1NPC1
SCHEMBL4658577 0.79 NPC1 (0.68) EGFRSRCKDM4EALDH1A1NPC1
SCHEMBL22443294 0.77 KDM4E (0.52) EGFRKDM4EALDH1A1ATML3MBTL1
SCHEMBL7487890 0.77 ALDH1A1 (0.70) EGFRKDM4EALDH1A1NPC1MAPT
SCHEMBL1388782 0.77 EGFR (1.00) EGFRSRCKDM4EALDH1A1NPC1
SCHEMBL7437202 0.76 ALDH1A1 (0.62) EGFRSRCKDM4EALDH1A1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110452235-A Fluorine isoxazole class compound and preparation method thereof, pharmaceutical composition and purposes SHANGHAI INST MATERIA MEDICA CAS 2019-11-15 CN disclosed
EP-3401315-A1 FXR RECEPTOR MODULATOR, PREPARATION METHOD THEREFOR, AND USES THEREOF Guangzhou Henovcom Bioscience Co. Ltd. (CN) 2018-11-14 EP disclosed
US-5556874-A ENZYME INHIBITORS AS ANTICARCINOGENIC AGENTS WARNER LAMBERT COMPANY (US) 1996-09-17 US disclosed
US-5464861-A Anticarcinogenic agents WARNER-LAMBERT (US) 1995-11-07 US disclosed
EP-0654024-A1 2-THIOINDOLES (SELENOINDOLES) AND RELATED DISULFIDES (SELENIDES) WHICH INHIBIT PROTEIN TYROSINE KINASES AND WHICH HAVE ANTITUMOR PROPERTIES WARNER-LAMBERT COMPANY (US) 1995-05-24 EP disclosed
WO-1994003427-A1 2-THIOINDOLES (SELENOINDOLES) AND RELATED DISULFIDES (SELENIDES) WHICH INHIBIT PROTEIN TYROSINE KINASES AND WHICH HAVE ANTITUMOR PROPERTIES WARNER-LAMBERT COMPANY (US) 1994-02-17 WO disclosed